Teva Pharmaceutical Industries Limited (TEVA) News Headlines

▮ More

Date

Headline

9/8/2021 8:28:25 AM Teva : Data Shows Ajovy Reduces More Monthly Migraine Days In Study With Atogepant And Rimegepant

9/8/2021 8:11:18 AM Teva Sees Migraine Treatment Landscape Continue To Advance; Data To Be Presented At Joint Congress 2021 On Sept 8-12

8/31/2021 4:30:44 PM FDA Accepts Teva, MedinCell NDA For Schizophrenia Treatment

8/30/2021 2:43:24 AM Biotech Stocks Facing FDA Decision In September 2021

8/20/2021 8:24:18 AM Teva Announces Long-Term Data Of Austedo In Adult Patients With Tardive Dyskinesia

8/20/2021 8:11:22 AM Teva Announces Analysis Of Long-Term Data Examining Treatment With AUSTEDO Tablets In Adult With Tardive Dyskinesia

7/28/2021 10:55:40 AM Teva Pharma Gains 10% After Reporting Q2 Results

7/28/2021 7:36:18 AM Independent Analysis Says Teva Generic Medicines Saved U.S. $28.8 Bln In 2020, Total Of $43.1 Bln Across Major Markets

7/28/2021 7:26:59 AM Teva Lowers FY Revenues Outlook

7/28/2021 7:12:27 AM Teva Pharmaceutical Industries Limited (TEVA) Has Lowered Its FY21 Revenue Estimate To $16.0 - $16.4 Bln From $16.4 - $16.8 Bln

7/28/2021 7:11:50 AM Teva Pharmaceutical Industries Limited Q2 adjusted earnings Inline With Estimates

7/28/2021 7:04:39 AM Teva Q2 GAAP EPS $0.19; Non-GAAP EPS $0.59

7/28/2021 7:00:09 AM Teva Pharmaceutical Industries Q2 21 Earnings Conference Call At 8:00 AM ET

7/20/2021 10:10:18 AM Three Drug Distributors To Pay Up To $1.18 Bln To Settle New York Opioid Claims

7/2/2021 3:55:38 AM Teva Recalls One Lot Of Topotecan Injection

6/28/2021 8:14:09 AM Teva, Bioeq Reach Deal To Commercialize Biosimilar Candidate Of Ophthalmology Drug Ranibizumab

6/23/2021 8:35:48 AM Teva : Japan Approves AJOVY Injection For Preventive Treatment Of Migraine In Adults

6/16/2021 7:49:07 AM Teva Launches Generic Version Of Ivermectin Cream, 1% In The U.S. - Quick Facts

6/3/2021 8:54:42 AM Teva Says Clinical Programs Reinforce The Potential AJOVY Can Have For Patients Living With Migraine

6/3/2021 8:23:10 AM Teva Pharma Presents New Data From Clinical And Real-world Analyses Examining The Efficacy Of AJOVY For Migraine At ASH